Immunai, the biotech platform focused on mapping the immune system with single-cell biology and Ai, has raised $20M in funding from investors that include TLV Partners and Viola Group. Immunai was founded by Ansuman Satpathy, Dan Littman, Daniel Wells, Luis F Voloch, and Noam Solomon in 2019.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.